These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16594633)

  • 1. The role of crystallography in drug design.
    Deschamps JR
    AAPS J; 2005 Dec; 7(4):E813-9. PubMed ID: 16594633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray crystallography of chemical compounds.
    Deschamps JR
    Life Sci; 2010 Apr; 86(15-16):585-9. PubMed ID: 19303027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of a series of meta aniline-based LFA-1 ICAM inhibitors.
    Guckian KM; Lin EY; Silvian L; Friedman JE; Chin D; Scott DM
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5249-51. PubMed ID: 18778938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diamond: shedding light on structure-based drug discovery.
    Brown DG; Shotton EJ
    Philos Trans A Math Phys Eng Sci; 2015 Mar; 373(2036):. PubMed ID: 25624512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of the absolute configuration of the potent histamine H3 receptor antagonist GT-2331 using vibrational circular dichroism.
    Minick DJ; Copley RC; Szewczyk JR; Rutkowske RD; Miller LA
    Chirality; 2007 Sep; 19(9):731-40. PubMed ID: 17575572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrocyclic peptidomimetic inhibitors of beta-secretase (BACE): first X-ray structure of a macrocyclic peptidomimetic-BACE complex.
    Rojo I; Martín JA; Broughton H; Timm D; Erickson J; Yang HC; McCarthy JR
    Bioorg Med Chem Lett; 2006 Jan; 16(1):191-5. PubMed ID: 16249081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.
    Cook BN; Bentzien J; White A; Nemoto PA; Wang J; Man CC; Soleymanzadeh F; Khine HH; Kashem MA; Kugler SZ; Wolak JP; Roth GP; De Lombaert S; Pullen SS; Takahashi H
    Bioorg Med Chem Lett; 2009 Feb; 19(3):773-7. PubMed ID: 19111460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structure-based approach to drug discovery; crystallography and implications for the development of antiparasite drugs.
    Hunter WN
    Parasitology; 1997; 114 Suppl():S17-29. PubMed ID: 9309766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chirality as a tool in nucleic acid recognition: principles and relevance in biotechnology and in medicinal chemistry.
    Corradini R; Sforza S; Tedeschi T; Marchelli R
    Chirality; 2007 May; 19(4):269-94. PubMed ID: 17345563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 6-ethyl-2,4-diaminopyrimidine-based small molecule renin inhibitors.
    Holsworth DD; Jalaie M; Belliotti T; Cai C; Collard W; Ferreira S; Powell NA; Stier M; Zhang E; McConnell P; Mochalkin I; Ryan MJ; Bryant J; Li T; Kasani A; Subedi R; Maiti SN; Edmunds JJ
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3575-80. PubMed ID: 17482464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
    Cancilla MT; He MM; Viswanathan N; Simmons RL; Taylor M; Fung AD; Cao K; Erlanson DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3978-81. PubMed ID: 18579375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk).
    Moriarty KJ; Takahashi H; Pullen SS; Khine HH; Sallati RH; Raymond EL; Woska JR; Jeanfavre DD; Roth GP; Winters MP; Qiao L; Ryan D; DesJarlais R; Robinson D; Wilson M; Bobko M; Cook BN; Lo HY; Nemoto PA; Kashem MA; Wolak JP; White A; Magolda RL; Tomczuk B
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5545-9. PubMed ID: 18819799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
    Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B; Mohr P; Stahl M
    J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.
    Sabio M; Jones K; Topiol S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5391-5. PubMed ID: 18829308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of novel glycomimetics: inhibitors of concanavalin A.
    Welch KT; Turner TA; Preast CE
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6573-5. PubMed ID: 18990567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using X-ray crystallography in drug discovery.
    Rowland RS
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):613-9. PubMed ID: 12197319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Form finds function.
    Allen KN
    Nat Chem Biol; 2007 Aug; 3(8):452-3. PubMed ID: 17637773
    [No Abstract]   [Full Text] [Related]  

  • 20. Structural studies of opioid peptides: a review of recent progress in x-ray diffraction studies.
    Deschamps JR; George C; Flippen-Anderson JL
    Biopolymers; 1996; 40(1):121-39. PubMed ID: 8541444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.